insulin-like growth factor I

DRUG4 trials

Sponsors

Beth Israel Deaconess Medical Center, Children's Hospital of Philadelphia, Bispebjerg Hospital

Conditions

HyperglycemiaHyperinsulinismInsulin ResistanceTendinopathy

Early Phase 1

Patellar Tendinopathy - Effect of Training and Enhancement of the Collagen Synthesis by Insulin-like Growth Factor-I

Bispebjerg HospitalTendinopathy

Start: 2013-04-30End: 2020-12-01Updated: 2020-07-29

Phase 2

Phase II Long Term, Randomized Study of Recombinant Human Insulin-like Growth Factor I in Children With Hyperinsulinism

CompletedNCT00004700

Children's Hospital of PhiladelphiaHyperinsulinism

Start: 1995-08-31End: 1999-01-31Target: 16Updated: 2015-03-25

Unknown Phase

Study of Recombinant Human Insulin-Like Growth Factor I in Patients With Severe Insulin Resistance

CompletedNCT00004419

Beth Israel Deaconess Medical CenterHyperglycemia, Insulin Resistance

Start: 1998-04-30End: 2000-09-30Target: 18Updated: 2015-03-25

Dose Ranging Study of Recombinant Human Insulin-like Growth Factor I in Children With Hyperinsulinism

CompletedNCT00004699

Children's Hospital of PhiladelphiaHyperinsulinism

Start: 1995-08-31End: 1999-01-31Target: 8Updated: 2015-03-25

Related Papers

No Treatment Benefits of Local Administration of Insulin-like Growth Factor-1 in Addition to Heavy Slow Resistance Training in Tendinopathic Human Patellar Tendons: A Randomized, Double-Blind, Placebo-Controlled Trial With 1-Year Follow-up

The American Journal of Sports Medicine2021-06-1729 citations